Agenus UK compared the Amperia platform with BLI and SPR for antibody titer analysis in cell line development.

Integrated analytical workflows are transforming cell line development by combining faster screening and streamlined decision-making.

QuantumScape has completed the installation of key equipment to enable higher-volume QSE-5 cell production – a key goal for ...

Researchers discovered that a long-misunderstood protein plays a key role in helping chromosomes latch onto the right “tracks ...

The loss of domvanalimab is the latest in a string of high-profile failures recorded across the biopharma world for the TIGIT ...

QuantumScape Corporation (NYSE: QS), a global leader in next-generation solid-state lithium-metal battery technology, today ...

Scientists identified cellular metabolism and energy signaling as a central factor connecting genetic and environmental ...

FT819 continues to demonstrate meaningful decrease in disease and favorable safety profile with twelve systemic lupus erythematosus (SLE) patients now treated; first systemic sclerosis (SSc) patient t ...

Arcus will now refocus its efforts outside of TIGIT, specifically on its asset casdatifan, an HIF-2a inhibitor once backed by Gilead, as well as its earlier stage small-molecule inflammatory and ...

With T-cell engagers already established as late-line therapies for certain blood cancers, Regeneron has released early data ...

Updated clinical data presented at ASH show robust efficacy, rapid onset of remission, high incidence of MRD1-negativity, and ...

Sydney-based Immutep and Dr Reddy’s Laboratories have inked an exclusive licensing agreement through their arms for the ...